Literature DB >> 30776342

Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor.

Patrice Cacoub1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30776342     DOI： 10.1053/j.gastro.2019.02.009

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

1.  Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost.

Authors:  Wai Hoong Chang; Stefanie H Mueller; Sheng-Chia Chung; Graham R Foster; Alvina G Lai
Journal:  J Transl Med       Date:  2022-01-03       Impact factor: 5.531

Review 2.  Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection.

Authors:  Iman Ibrahim Salama; Hala M Raslan; Ghada A Abdel-Latif; Somaia I Salama; Samia M Sami; Fatma A Shaaban; Aida M Abdelmohsen; Walaa A Fouad
Journal:  World J Hepatol       Date:  2022-06-27

Review 3.  Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel?

Authors:  Giorgio Maria Saracco; Alfredo Marzano; Mario Rizzetto
Journal:  Biomedicines       Date:  2022-02-24

4.  Hepatitis C Virus Clearance by Direct-Acting Antivirals Agents Improves Endothelial Dysfunction and Subclinical Atherosclerosis: HEPCAR Study.

Authors:  Rocío Muñoz-Hernández; Javier Ampuero; Raquel Millán; Antonio Gil-Gómez; Ángela Rojas; Hada C Macher; Rocío Gallego-Durán; Sheila Gato; Rocío Montero-Vallejo; María C Rico; Douglas Maya-Miles; Yolanda Sánchez-Torrijos; Isabel Carmona Soria; Pablo Stiefel; Manuel Romero-Gómez
Journal:  Clin Transl Gastroenterol       Date:  2020-08       Impact factor: 4.396
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.